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The convergence of APP (substrate) and BACE-1
(enzyme) is a rate-limiting, obligatory event triggering
the amyloidogenic pathway—a key step in Alz-
heimer’s disease (AD) pathology. However, as both
APP/BACE-1 are highly expressed in brain, mecha-
nisms precluding their unabated convergence are
unclear. Exploring dynamic localization of APP/
BACE-1 in cultured hippocampal neurons, we found
that after synthesis via the secretory pathway, den-
dritic APP/BACE-1-containing vesicles are largely
segregated in physiologic states. While BACE-1 is
sorted into acidic recycling endosomes, APP is
conveyed in Golgi-derived vesicles. However, upon
activity induction—a known trigger of the amyloido-
genic pathway—APP is routed into BACE-1-positive
recycling endosomes via a clathrin-dependent
mechanism. A partitioning/convergence of APP/
BACE-1 vesicles is also apparent in control/AD
brains, respectively. Considering BACE-1 is opti-
mally active in an acidic environment, our experi-
ments suggest that neurons have evolved trafficking
strategies that normally limit APP/BACE-1 proximity
and also uncover a pathway routing APP into
BACE-1-containing organelles, triggering amyloido-
genesis.
INTRODUCTION
The amyloid precursor protein (APP) is sequentially cleaved to
generate amyloid-beta (Ab) peptides—pathologic hallmarks of
Alzheimer’s disease (AD)—via the ‘‘amyloidogenic pathway.’’
The rate-limiting step in this pathway is the cleavage of APP by
the aspartyl protease b-site APP-cleaving enzyme-1 (BACE-1),
making the physical proximity of APP (substrate) and BACE-1
(enzyme) an obligatory step initiating this pathway (Thinakaran
and Koo, 2008). As continued proximity of APP/BACE-1 mightlead to relentless pathology, it seems reasonable that cellular
pathways would spatially segregate this enzyme/substrate pair
in physiologic states. However, to date, the precise trafficking
pathways of APP and BACE-1 in neurons—including mecha-
nisms that dictate divergence/convergence of these two pro-
teins—are unclear.
While previous studies have examined the subcellular localiza-
tion of the transmembrane proteins APP and BACE-1, there are
two major caveats. First, most studies have been performed in a
variety of nonneuronal cells or neuronal cell lines that lack the
unique morphology and compartmentalization of neurons.
Accordingly, reported locales of these proteins range from the
endoplasmic-reticulum (ER)/Golgi, cell membranes/lipid rafts,
to endosomal-lysosomal organelles (Greenfield et al., 1999; Ehe-
halt et al., 2003; reviewed in Brunholz et al., 2012 and Rajendran
and Annaert, 2012). Furthermore, most have examined the traf-
ficking of mutant (and not wild-type) APP. Second, the vast ma-
jority of studies have been performed in fixed cells and have not
fully accounted for the dynamic nature of these peptides that are
continuously trafficking in neurons (see below). Importantly,
vesicle-trafficking pathways in highly polarized cells like neurons
are unique compared to other cell types. For instance, neurons
have an extensive and sophisticated network of recycling endo-
somes that are scattered throughout the processes, unlike
nonneuronal cells, in which this system is relatively small and
typically clustered around the nucleus (Yap and Winckler,
2012). Although some studies have examined APP/BACE-1 traf-
ficking in polarized epithelial cells, extrapolation of these data to
neurons has been complicated (reviewed in Haass et al., 2012).
Toward this, we explored the dynamic localization of APP and
BACE-1 in cultured hippocampal neurons, expressing low levels
of fluorescent-tagged proteins and examining their trafficking
and organelle composition in neuronal soma and processes
with high resolution. We also designed imaging paradigms that
revealed basic mechanisms leading to APP/BACE-1 conver-
gence and initiation of the amyloidogenic pathway. Finally, we
also examined the spatial localization of these proteins in mouse
and human brains in vivo. Our data reveal surprising aspects of
neuronal APP/BACE-1 trafficking that are quite different from
that seen in other simpler cell types and also help define amech-
anistic pathway for activity-dependent amyloidogenesis.Neuron 79, 447–460, August 7, 2013 ª2013 Elsevier Inc. 447
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Segregation of APP and BACE-1 into Distinct Neuronal
Microdomains
We first visualized the trafficking of APP and BACE-1 in neurons.
Toward this, we transfected cultured hippocampal neurons with
low levels of APP/BACE-1 tagged to green/red fluorescent pro-
teins (GFP/mCherry, see Figures S1A–S1D available online) and
simultaneously visualized their trafficking in somatodendritic
compartments after 4–6 hr—a time when these fusion proteins
are just starting to be expressed (schematic in Figure 1A). We
focused on somatodendritic compartments, as the spatial sepa-
ration/convergence of APP/BACE-1 fluorescence could be
confidently evaluated in these wider profiles (see below); recent
reports also implicate dendrites in APP processing (Wei et al.,
2010; Wu et al., 2011). Tubulovesicular structures carrying APP
and BACE-1 moved bidirectionally within the dendritic shaft
and the movement was microtubule dependent, resembling
the movement of motor-driven vesicular cargoes (Figures S1E
and S1F; Movie S1; Table S1; also see Tang et al., 2012). As
shown in the kymographs (Figure 1B), localization of both sta-
tionary and mobile APP/BACE-1 particles were largely nonover-
lapping (Figure 1B, bar graph). Subtle differences were also seen
in the transport kinetics of APP and BACE-1 vesicles (Figure 1C),
further suggesting that these two cargoes were largely conveyed
in distinct organelles.
Next, to examine the biogenesis of APP/BACE-1 cargoes,
we focused on the distribution of these proteins within the
neuronal soma. As both APP and BACE-1 are transmembrane
proteins, they would be expected to traffic via the ER/Golgi
(biosynthetic) pathway. In accordance with this, we found sig-
nificant colocalization of APP and BACE-1 in the perinuclear
region (Figure 1D)—a distribution reminiscent of the ER-Golgi
network in these neurons (Dresbach et al., 2006; also see
overlap with Golgi marker galactosyl-transferase [GalT] below).
However, we also saw BACE-1 particles (Figure 1D, arrow-
heads) that did not colocalize with APP, suggesting that
BACE-1 may be sorted into a distinct compartment after traf-
ficking via the ER/Golgi pathway. If the latter was true, condi-
tions inhibiting the emergence of Golgi-derived vesicles would
be expected to ‘‘trap’’ APP/BACE-1 within the Golgi network.
To test this idea, we incubated cultured neurons at 20C for
2 hr—conditions expected to block the exit of Golgi-derived
proteins (Dresbach et al., 2006). Indeed, we found that the peri-
nuclear colocalization of APP/BACE-1 was significantly
increased under these conditions (Figure 1D, inset), further
suggesting that the subset of somatic BACE-1 that failed to
colocalize with APP at 37C was a consequence of post-Golgi
processing. Increased colocalization of BACE-1 with GalT at
20C also supports this overall model (Figure 1D). Moreover,
APP/BACE-1 colocalization decreased over 6–36 hr posttrans-
fection (Figure 1D, bottom), further suggesting a differential
sorting after biogenesis. The spatial segregation of APP and
BACE-1 was also evident in sucrose density gradients of
P100 (‘‘vesicle pellet’’; DeBoer et al., 2008; see fractionation
strategy in Figure S1G) mouse brain fractions in vivo, in which
endogenous holo-APP/BACE-1 were largely localized to
distinct fractions (Figure 1E).448 Neuron 79, 447–460, August 7, 2013 ª2013 Elsevier Inc.BACE-1 Is Largely Conveyed in Neuronal Recycling
Endosomes
Next, we sought to determine the specific organelles carrying
BACE-1 and APP in neurons. Accordingly, we cotransfected
fluorescent-tagged BACE-1 (or APP) with various labeled organ-
elle markers known to highlight specific biosynthetic or endoso-
mal organelles (Yap and Winckler, 2012) and simultaneously
visualized the trafficking of BACE-1/organelle markers in den-
drites by live imaging. While only 10%–30% of the mobile
BACE-1 vesicles colocalizedwithGolgimarkers (see below), sur-
prisingly, the vast majority of BACE-1 was conveyed in vesicles
that are known markers of neuronal recycling endosomes (Fig-
ures 2A–2C). Specifically, we simultaneously visualized transport
of BACE-1:GFP and TfR:mCherry—previously used as a marker
for neuronal recycling endosomes (Park et al., 2006; Wang et al.,
2008). The TfR fusion construct faithfully represents a functional
recycling pool, as shown in Figure S2. Indeed, the vastmajority of
the trafficking BACE-1 vesicles colocalized with TfR (Figures
2A–2C) and also syntaxin-13 (Figure 2B, middle)—known
markers of dendritic recycling endosomes (Park et al., 2006; Pre-
keris et al., 1999; Silverman et al., 2001; Wang et al., 2008; Yap
and Winckler, 2012). In contrast, few mobile BACE-1 vesicles
colocalized with Rab5, a marker for early endosomes (Figure 2B,
bottom). However, unlike mobile vesicles, stationary BACE-1
cargoes colocalized with all tested markers (TfR, syntaxin 13,
and Rab5; Figure 2B). The significance of this is unclear, but
such stationary particles are commonly seen when imaging
vesicle transport in axons (for example, see Tang et al., 2012)
and may represent sites where potential intermingling of biosyn-
thetic and recycling organelles occur.
Next, we asked whether APP colocalized with known markers
of the neuronal biosynthetic pathway. Toward this, we cotrans-
fected neurons with APP:mCherry and the signal sequence of
neuropeptide-Y (NPYss) fused toGFP—the latter expected to la-
bel the interior of Golgi-derived vesicles (El Meskini et al., 2001;
Kaech et al., 2012). Indeed, the vast majority of APP vesicles co-
localized with NPYss (Figure 2D, middle), while there was only
20% colocalization of moving BACE-1 particles with NPYss
(Figure 2D, right). Notably, <30%ofmobile APP vesicles colocal-
ized with TfR (27.92% ± 7.0%/8.33% ± 5.45%, mean ± SEM;
APP:GFP anterograde/retrograde particles respectively colocal-
izing with TfR:mCherry). Finally, P100 density gradients from
mouse brains showed that fractions containing endogenous
BACE-1 overlapped with a subset of TfR-positive vesicles,
though colocalizationwith othermarkerswere variable (Figure 2E
and Figure S3). A schematic view summarizing the above data is
presented in Figure 2F.
Activity-Induced Convergence of APP and BACE-1
Occurs Largely in Recycling Compartments
The above experiments suggest that the majority of APP and
BACE-1 vesicles are spatially segregated and that APP/BACE-
1 colocalization is a low-frequency event under basal conditions.
As physical proximity of APP and BACE-1 is an obvious require-
ment for initiating APP cleavage, we reasoned that conditions
triggering Ab generation (i.e., BACE-1 cleavage) should also
increase APP/BACE-1 colocalization. Substantial evidence indi-
cates that enhanced neuronal activity leads to an increase in
Figure 1. Segregation of APP and BACE-1 into Distinct Neuronal Microdomains
(A) Generic plan for transport experiments. Cultured hippocampal neurons were transfected with tagged APP/BACE-1 (or other) constructs, vesicle transport in
dendrites was imaged live after 4–6 hr, and resultant kymographs were analyzed (see Experimental Procedures for more details).
(B) Representative kymographs from simultaneous APP:GFP and BACE-1:mCherry imaging. Pseudocolor overlay of the two kymographs (top right), with mobile
tracks marked (below right). Note little overlapping of mobile and stationary APP and BACE-1 vesicles, quantified in the bar graph below.
(C) Velocity histograms of mobile APP and BACE-1 vesicles were best fitted by two ‘‘peaks’’ (arrowheads; also see Tang et al., 2012), with subtle differences in
anterograde transport kinetics. The distribution of first and second anterograde peaks for APP and BACE was significantly different (APP: 0.33/0.67; BACE: 0.5/
0.5; first and second peak, respectively; p = .0216), while distribution of first and second retrograde peaks was not (APP: 0.29/0.71; BACE: 0.45/0.55, first and
second peak, respectively; p = 0.2549). For both (B) and (C) nearly 100 APP particles and 150BACE-1 particles in 15–20 neuronswere analyzed from two separate
culture sets.
(D) Neurons were transfected with BACE-1:mCherry and APP:GFP as above, and BACE-1/APP distribution in the soma was analyzed after 4–6 hr. Note that
although a large fraction of the BACE-1 colocalizes with APP in a perinuclear ER/Golgi pattern, vesicles containing BACE-1 (but not APP) are also seen
(arrowheads). Incubation of neurons at 20C for 2 hr (expected to block exit of vesicles from the Golgi) greatly increases BACE-1/APP colocalization. Similar
results were obtained with BACE-1 and GalT, a Golgi marker. Over time, the extent of APP/BACE-1 colocalization was also diminished, further suggesting
differential redistribution of these two proteins after biogenesis. nz 15 neurons analyzed for each temperature/time point, from at least two separate cultures.
*p < 0.05; **p < 0.01; ***p < 0.001; two-tailed, unpaired t test.
(E) Sucrose density gradients from ‘‘vesicle-pellet’’ fractions of mouse brains (see text) show that endogenous APP and BACE-1 is also largely segregated in vivo.
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Figure 2. Trafficking of BACE-1 in Recycling Endosomes
(A) Neurons were cotransfected with BACE-1:GFP (or BACE-1:mCherry) and either markers of recycling endosomes (TfR:mCherry or Syntaxin-13:GFP) or a
marker of early endosomes (Rab5:mCherry), and the BACE-1/endosomal organelles were simultaneously tracked by live imaging. Panels on the left show a still
frame from a dual-color movie of a dendrite transfected with BACE-1:GFP and TfR:mCherry. Note the striking colocalization of BACE-1/TfR distribution (two
vesicles are marked with arrowheads, scale bar represents 5 mm). The kymographs on right highlight the cotransport of BACE-1/TfR particles in the movie.
(B) Quantification: note that the majority of mobile BACE-1 particles are cotransported with markers of recycling endosomes. Although BACE-1 colocalized with
stationary Rab5 +ve organelles, there was little colocalization of BACE-1 with mobile Rab5. Also note that the BACE-1/TfR colocalization data suggest that
BACE-1 is present in a subset of TfR +ve vesicles. Nearly 150 BACE-1, 200 TfR, 220 Syntaxin-13, and 60 Rab5 particles were analyzed in 15 neurons from two
separate cultures.
(C) Active recycling endosomes were labeled by incubating neurons with Alexa 488 Tf (see Experimental Procedures). These methods labeled a subset of all
TfR:mCherry-positive vesicles, as expected (Figure S2). The vast majority of Alexa 488 Tf-labeled vesicles were colocalized/cotransported (arrowheads) with
BACE-1:mCherry in dendrites. For quantification, nearly 150 BACE-1 and 100 Alexa 488 Tf particles in ten neurons were analyzed from two culture sets.
(D) A large fraction of APP (but not BACE-1) is cotransported with NPYss:mGFP—a marker expected to label the interior of Golgi-derived vesicles (Kaech et al.,
2012). Nearly 120 APP, 150 BACE-1, and 150 NPYss:mGFP particles were analyzed in 15 neurons from two separate culture sets.
(E) Sucrose density gradients from ‘‘vesicle-pellet’’ fractions of mouse brains (see text) show an overlap of endogenous BACE-1, a subset of TfR-containing
vesicles, but little overlap with the Golgi marker GM-130.
(F) Summary schematic. After synthesis in the ER/Golgi, BACE-1 is routed into recycling endosomes, whereas APP remains in Golgi-derived vesicles, leading to a
spatial segregation of these two cargoes under physiologic conditions.
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Figure 3. Activity-Dependent Convergence of APP and BACE-1
(A) Schematic of experiments to induce activity. Neurons were cotransfected with APP:GFP and BACE-1:mCherry, neurons were stimulated with glycine or
picrotoxin (PTX), and the colocalization of APP and BACE-1 fluorescence was analyzed (see Experimental Procedures for more details).
(B) Note that stimulation with glycine greatly increased APP/BACE-1 colocalization in dendrites (overlaid images on right).
(C and D) Quantification of APP/BACE-1 colocalization. Note that increases in glycine-induced APP/BACE-1 convergence can be blocked by the NMDA receptor
blockers D-AP5 and memantine. n z 15 neurons analyzed for each condition, from at least three separate culture sets. *p < 0.05; **p < 0.01; ***p < 0.001
compared to control by one-way ANOVA followed by Dunnet’s post hoc test (C) and *p < 0.05; **p < 0.01; ***p < 0.001; two-tailed, unpaired t test (D).
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et al., 2005, 2008; Kamenetz et al., 2003, reviewed in Haass
et al., 2012; also see Figures 4D and 4E below). Accordingly,
we first asked whether induction of neuronal activity in our model
system would also increase APP/BACE-1 colocalization.
To test this idea, we transfected tagged APP and BACE-1 in
cultured neurons (as above) and stimulated the neurons using es-
tablished paradigms (see schematic in Figure 3A). Indeed, stimu-
lation of neurons with glycine (Lu et al., 2001; Park et al., 2006)
resulted in a significant increase in APP/BACE-1 convergence(Figures 3B and 3C). Preincubation of neurons with inhibitors of
NMDA receptors prevented this colocalization (Figure 3C), indi-
cating that these changes are a consequence of glycine and
NMDA receptor-mediated pathway. Similar results were ob-
tained when neurons were stimulated with K+ (data not shown).
As an alternative approach, stimulation of neurons using the
GABAAantagonistPicrotoxin (PTX)—known to increase neuronal
activity in hippocampal cultures, presumably due to suppression
of inhibitory inputs (Neuhoff et al., 1999;Bateupet al., 2011)—also
led to an increase in APP/BACE-1 convergence (Figure 3D).Neuron 79, 447–460, August 7, 2013 ª2013 Elsevier Inc. 451
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converge upon stimulation? As neuronal BACE-1 is largely local-
ized to recycling endosomes in physiologic states (see above),
we asked whether activity-induced APP/BACE-1 convergence
increased APP/recycling-endosome colocalization as well. To
test this hypothesis, we cotransfected neurons with APP:GFP
and TfR:mCherry and then quantified their colocalization in den-
drites after stimulation with glycine and PTX in fixed neurons (see
schematic in Figure 4A). Indeed, a larger fraction of APP was
colocalized with TfR-positive vesicles in stimulated neurons (Fig-
ure 4B). Similar experiments with APP:GFP andRab5:mCherry (a
marker for early endosomes) showed no changes in APP/Rab5
colocalization upon stimulation (Figure 4C, left). Similarly,
BACE-1 colocalization with Rab5 was also unchanged upon
activity induction as well (Figure 4C, right). Treatment of neurons
with a b-secretase inhibitor did not influence the activity-induced
changes in the APP/BACE-1 (or APP/TfR) convergence
(Figure S4A).
The above data in fixed neurons suggest that APP and
BACE-1 colocalize upon activity induction. Next, we specifically
asked whether mobile APP and BACE-1 vesicles converged
upon activity induction. Toward this, we cotransfected neurons
with APP:GFP and BACE-1:mCh and then stimulated them
with PTX. As shown in representative kymographs (Figure 4D)
and the quantification (Figure 4E), there was a striking increase
in colocalization of moving APP/BACE-1 (and also APP/TfR) ves-
icles in the PTX-treated cells, suggesting that the mobile APP/
BACE-1 particles were converging in recycling compartments
upon activity induction. Finally, stimulation of neurons led to
expected increases in b-CTF generation (Figures 4F and 4G).
Taken together, these results indicate that upon neuronal activ-
ity, APP is redistributed to recycling endosomes enriched
in BACE, thus facilitating b-secretase cleavage and b-CTF
generation.
Activity-Induced Routing of APP into Acidic
Microdomains
It has been known for some time that the aspartyl-protease
BACE-1 is optimally active in an acidic pH (Vassar et al., 2009).
As the intraluminal pH of recycling endosomes is also acidic
(Park et al., 2006 and also see below), it is possible that routing
of APP into acidic recycling endosomes is a key event preceding
its cleavage. To test this idea directly, we used a pH-sensitive
GFP (pHluorin) tagged to the N terminus (intraluminal end) of
APP (Groemer et al., 2011) and visualized trafficking of pHl:APP
in dendrites by live imaging (see schematic in Figure 5A).
First, to test the pHluorin construct, we cotransfected neurons
with pHl:APP and soluble mCherry and monitored the fluores-
cence before/after lowering the pH of the media to 5.5, which
would be expected to globally acidify subcellular compartments
(Park et al., 2006). Note that the acidic pH dramatically quenches
the pHl:APP but has no effect on the soluble mCherry fluores-
cence in the same neuron (Figure 5B), reflecting the reliability
of this pH-sensitive reporter. Figure 5C shows representative
kymographs of pHl:APP in dendrites before and after glycine
stimulation. Note the decrease in mobile pHl:APP particles,
with little change in the stationary vesicle population (quantified
in Figure 5D, left). Similar experiments with APP tagged to con-452 Neuron 79, 447–460, August 7, 2013 ª2013 Elsevier Inc.ventional GFP showed only a slight (nonsignificant) decrease in
mobile vesicles after stimulation (Figure 5D, below). Moreover,
we saw clear instances in which the fluorescence of pHl:APP
was abruptly quenched upon stimulation (see example in Fig-
ure 5E). Though such events were occasionally seen in control
neurons (andwe could only document them reliably in transiently
paused APP vesicles), the incidence was significantly increased
upon stimulation (Figure 5E, graph and Movie S2). Thus collec-
tively, these experiments indicate that APP is routed into acidic
compartments upon stimulation. As above, treatment of neurons
with a b-secretase inhibitor did not influence the activity-induced
changes in pHl-APP kinetics (Figure S4B).
Clathrin-Mediated Endocytosis of APP Is Required for
APP/BACE-1 Convergence
The above data suggest that neuronal activity leads to conver-
gence of APP vesicles with acidic recycling endosomes contain-
ing BACE-1, leading to two possible mechanistic scenarios. One
possibility is that upon activity induction, vesicles containing
APP undergo endocytosis at the plasma membrane, and the
endocytosed APP subsequently merges with BACE-1-positive
recycling endosomes (Figure 6A, pathway [1]). Alternatively,
APP/BACE-1 vesicles could undergo homotypic fusion (Fig-
ure 6A, pathway [2]). To distinguish between these two possibil-
ities, we used the dynamin inhibitor dynasore—a drug expected
to block clathrin-mediated endocytosis (CME) (Macia et al.,
2006). To first characterize the effects of dynasore on CME in
cultured neurons, we transfected neurons with clathrin:GFP
and visualized its assembly/disassembly (‘‘on/off’’) dynamics in
dendrites, known to represent coating/uncoating events in
CME (Blanpied et al., 2002). Incubation with dynasore signifi-
cantly increased the lifetimes of clathrin-coated pits (CCPs) in
dendrites (Figure 6B).
To examine the effects of endocytosis inhibition on APP/
BACE-1 colocalization, we transfected neurons with APP:GFP
and BACE-1:mCherry, stimulated them with glycine in the pres-
ence or absence of dynasore, and quantified APP/BACE-1
colocalization. The main goal here was to test whether inhibition
of endocytosis blocked APP/BACE-1 colocalization. As shown in
the representative panels (Figure 6C) and the quantification
below (Figure 6D), dynasore treatment essentially abolished
the activity-dependent convergence of APP/BACE-1. However,
a caveat in this experiment is that dynasore treatment would
inhibit all endocytic trafficking (not just APP) and may also sup-
press neuronal activity. Thus, to address whether the specific
inhibition of APP endocytosis would prevent its activity-induced
redistribution into BACE-1-positive endosomes, we transfected
neurons with APP:GFP carrying a mutation in the APP-endocy-
tosis domain (APP-YENPTY) that is known to inhibit APP endo-
cytosis (Perez et al., 1999). Indeed the APP-YENPTY mutant
failed to converge with BACE-1 vesicles upon stimulation (Fig-
ure 6D, image and right bar), further arguing that endocytosis
of APP is specifically required for activity-dependent APP/
BACE-1 convergence. Incubation of neurons with dynasore
also greatly abrogated stimulation-induced increases in
b-CTFs (Figure S4C). Finally, incubation of neurons with dyna-
sore did not alter any parameter of APP/BACE-1 transport in
dendrites (Figure S4D).
Figure 4. Routing of APP into Recycling Endosomes and Increased b-Cleavage upon Activity Induction
(A) Schematic of experiments. Neurons were cotransfected with APP:GFP and TfR:mCherry/Rab-5:mCherry to label the recycling/early endosomal compart-
ments, respectively, stimulated by glycine or picrotoxin (see Experimental Procedures), and colocalization of APP/TfR was analyzed in dendrites of fixed or living
neurons.
(B) Note the increased colocalization of APP with TfR +ve vesicles upon stimulation.
(C) APP or BACE-1 colocalization with Rab5 was unchanged upon stimulation. For (B) and (C), nz 20 neurons analyzed for each condition, from at least three
separate cultures sets. *p < 0.05; **p < 0.01; ***p < 0.001; two-tailed, unpaired t test.
(D) Transfected neurons were imaged before and after stimulation with PTX. While there was little convergence of moving APP and BACE-1 vesicles in control
dendrites as expected (kymographs on left), significant convergence was seen upon PTX stimulation (kymographs on right). Note that to help visualization,
noncolocalized diagonal tracks are highlighted in the overlaid kymographs by green/red lines.
(E) Quantification of (D). Note increased colocalization of moving (but not stationary) APP/BACE-1 upon PTX stimulation. Similar experiments with APP:GFP and
TfR:mCherry showed an increased colocalization of motile APP/TfR vesicles upon PTX stimulation. nz 200–300 particles analyzed for each condition in 15–20
neurons from at least two separate cultures. ***p < 0.001; two-tailed, unpaired t test.
(F and G) Western blots in (F), with quantification in (G), demonstrating that increased neuronal activity enhances b-cleavage of APP. Cultured neurons were
incubated with picrotoxin (to induce activity) and a g-secretase inhibitor (to inhibit subsequent g-cleavage and degradation of b C-terminal fragments [b CTFs]).
APP fragments were analyzed by western blotting (see Experimental Procedures for more details). Note that these treatments lead to clear increases in b CTFs,
quantified in (F) (*p < 0.05; two-tailed, unpaired t test).
Neuron
Activity-Induced APP/BACE-1 Convergence
Neuron 79, 447–460, August 7, 2013 ª2013 Elsevier Inc. 453
Figure 5. Mobile APP Particles Are Routed into an Acidic Microenvironment upon Activity Induction
(A) Schematic of pHluorin:APP. Note that the pHluorin is tagged to the N terminus (intraluminal) end and would be expected to quench if APP enters into vesicles
with an acidic luminal pH (i.e., recycling endosomes).
(B) To test the pHl:APP construct, we cotransfected neurons with pHl:APP and soluble mRFP and transferred them to an acidic environment (see Experimental
Procedures). Note that while the fluorescence of the pHl:APP is dramatically quenched, there is no change in the fluorescence of soluble mRFP (all images are
identically scaled, intensity ‘‘heat maps’’ shown).
(C) Neurons were transfected with pHl:APP, and vesicle motility was analyzed—in the same dendrite—before and after stimulation. As shown in the repre-
sentative kymographs (motile vesicles are traced below), though there was no change in the intensities of stationary APP particles, the number of mobile APP
particles in dendrites were dramatically reduced after stimulation.
(D) Top: quantification of motile APP particles highlights the dramatic decease upon stimulation, with little change in stationary vesicles. Bottom: similar
experiments with APP tagged to conventional GFP do not show significant decreases in mobile particles upon stimulation. nz 100–200 particles analyzed for
each condition in 10–15 neurons from at least two separate cultures. *p < 0.05; **p < 0.01; ***p < 0.001; two-tailed, unpaired t test.
(E) Upon stimulation, instances of pHl-APP quenching were also seen as shown in selected frames from a time-lapse (also see Movie S2), further suggesting that
APP was routed into an acidic compartment upon induction of neuronal activity. We analyzed 10–50 quenching events in 10–20 neurons; duration of each movie
was 3 min (*p < 0.05; two-tailed, unpaired t test).
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Figure 6. APP/BACE-1 Convergence Requires Clathrin-Dependent Endocytosis of APP
(A) A schematic of the logic behind these experiments. The stimulation-dependent APP/BACE-1 convergence (see above) may either result from endocytosis of
APP-carrying vesicles with the plasmamembrane (PM) and subsequent entry of endocytosed APPmolecules into recycling compartments (pathway [1]) or could
be the result of a homotypic fusion of APP/BACE-1 carrying vesicles (pathway [2]).
(B) Upon adding dynasore—an inhibitor of dynamin—the number of clathrin-coated pits (CCPs) in dendrites—as measured by on/off kinetics of clathrin:GFP—
were reduced. Nearly 250–300 clathrin:GFP particles were analyzed for each condition in 10–15 neurons from at least two separate culture sets.
(C and D) Representative images (C) and quantification (D), showing that stimulation of neurons in the presence of dynasore essentially abolished APP/BACE-1
convergence. A similar inhibition of APP/BACE-1 convergence was seen using an ‘‘endocytosis-incompetent’’ APP construct (YENPTY mutant, see Results),
suggesting that the abrogation of APP/BACE-1 convergence was specifically related to endocytosis of APP. nz 15 neurons analyzed for each condition, from at
least three separate culture sets. ***p < 0.001 compared to control by one-way ANOVA followed by Dunnet’s post hoc test.
(E) To visualize potential APP/clathrin interactions on the dendritic surface, we transfected neurons with clathrin:GFP and APP:mCherry, and GFP/RFP mobility
was simultaneously visualized before and after adding dynasore (schematic on top). Note the typical on/off events of clathrin:GFP and bidirectional mobility of
APP before adding dynasore (‘‘before’’ kymographs, left). However, upon stimulation in the presence of dynasore, the vast majority of clathrin/APP particles are
stationary in dendrites (stalled vesicles marked with asterisks). Inset: a motile APP particle (red) transiently pauses at sites with stalled CCPs (green) before
coming to a stop (presumably being ‘‘trapped’’ in a stalled CCP, arrowheads).
(F) Note dramatic increases in stationary APP particles upon dynasore + glycine treatment. Similar experiments with BACE-1:mCherry did not show significant
changes in mobile fractions. Nearly 100–120 APP and BACE-1 particles were analyzed in eight to ten neurons from two culture sets.
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Activity-Induced APP/BACE-1 ConvergenceTo further clarify that the stimulation-induced APP endocy-
tosis is clathrin dependent, we directly looked at APP and
clathrin. We reasoned that if APP endocytosis was clathrin
dependent, blocking endocytosis in the setting of stimulation
would inhibit the retrieval of APP from the plasma membrane
and result in the stalling (and colocalization) of APP and clathrin
molecules at the surface. To test this idea, we cotransfected
neurons with clathrin:GFP and APP:mCherry and simultaneously
visualized both clathrin and APP fluorescence by dual-color live
imaging before and after glycine stimulation (see schematic in
Figure 6E). Representative kymographs from one such experi-
ment are shown in Figure 6E. Note that before adding dynasore,
dynamics of clathrin and APP are largely distinct in dendrites.
Expectedly, clathrin shows typical on/off kinetics while APP par-
ticles move bidirectionally. However, when activity is induced in
the presence of dynasore, the vast majority of clathrin and APP is
colocalized (Figure 6E, right kymographs). In this setting, we also
saw instances in which mobile APP particles were seemingly
‘‘captured’’ into stalled CCPs (Figure 6E, right). Quantification
of APP movements in control and ‘‘glycine + dynasore’’-treated
groups reveals a dramatic increase in stationary APP vesicles in
the latter group (Figure 6F, left). However, there were no signifi-
cant changes in BACE-1:GFP trafficking upon incubation with
glycine and dynasore (Figure 6F, right). Collectively, these data
further underline that the endocytosis of APP upon activity
induction is clathrin dependent and also suggest that the mobile
fraction of APP participates in this process.
Convergence of APPandBACE-1 in Alzheimer’sDisease
Brains
Finally, we reasoned that if pathologic changes occurring in AD
brains were mechanistically similar to the events suggested by
our data above, one may see APP/BACE-1 convergence in AD
brains as well. To test this, we took a biochemical approach.
P100 ‘‘membrane pellets’’ were obtained from ten postmortem
frozen human AD (and control) brain homogenates, and localiza-
tion of endogenous APP and BACE-1 was evaluated in sucrose
density gradients (see fractionation strategy in Figure S1G). We
found that while a spatial segregation of APP/BACE-1 was
evident in age-matched control brains (Figure 7A, top, similar
to mouse brains, compare with Figure 1E), in AD brains, signifi-
cant amounts of APP was redistributed to higher-density frac-
tions as well. Distribution of endogenous TfR in human brains
(Figure 7A, bottom) also overlapped with the BACE-1 fractions
(similar to mouse brains, compare with Figure 2E). These data
are quantified in Figures 7B and 7C. Note that average APP in-
tensity in AD brains (tenth fraction) is significantly higher than
controls (Figure 7C). Western blots showing APP distribution in
all control and AD brains, as well as distribution of various organ-
elle markers, are shown in Figures S5 and S6A. Similar density
gradients from a transgenic AD mouse model (J20) also sug-
gested a shift in APP distribution to BACE-1-enriched higher-
density fractions (Figure S6B).
DISCUSSION
As both APP and BACE-1 are highly expressed in brains, and
as cleavage of APP by BACE-1 is the rate-limiting step in the456 Neuron 79, 447–460, August 7, 2013 ª2013 Elsevier Inc.‘‘amyloid pathway,’’ an outstanding question relates to basic
cellular mechanisms that limit or facilitate the convergence of
APP and BACE-1 in neurons. Here we explored the dynamic
localization of APP and BACE-1 using cultured hippocampal
neurons as a model system and also validated key predictions
derived from these experiments in vivo. We found that after
synthesis, APP and BACE-1 are largely sorted into distinct traf-
ficking organelles, but neuronal activity—a known trigger of
amyloidogenesis—routed APP into BACE-1-containing acidic
organelles via clathrin-dependent endocytosis. As BACE-1 is
optimally active in an acidic pH, our experiments suggest that
neurons have evolved unique trafficking strategies that limit
APP/BACE-1 proximity, and we speculate that sporadic AD
pathology results from the breakdown of such well-orches-
trated trafficking pathways.
Spatial Segregation of APP and BACE-1 in Physiologic
States
We found that a large fraction of vesicles carrying APP and
BACE-1 are spatially segregated in neurons, both in a reduced
cell-culture system (Figures 1B–1D) and in mouse (Figure 1E)
and human brains (Figure 7). Though both transmembrane pro-
teins are synthesized via the ER/Golgi as expected, BACE-1
is subsequently present in recycling endosomes. Though the
exact steps by which this sorting occurs are unclear (true for
neuronal cargoes in general, see Yap and Winckler, 2012), our
data showing that BACE-1 vesicles are cotransported with
several markers of recycling endosomes (Figures 2A–2C) argue
that BACE-1 is largely conveyed in recycling endosomes. We
posit that this simple spatial separation limits APP cleavage by
BACE-1 under normal conditions, perhaps leading to the low
levels of Ab physiologically detected in human brains and cere-
brospinal fluid.
A Pathway for Activity-Dependent Convergence of APP
and BACE-1
Substantial evidence indicates that neuronal activity triggers
amyloidogenesis (reviewed in Haass et al., 2012). We found
that various paradigms inducing activity in cultured neurons
also led to increased colocalization of APP/BACE-1, as well as
a routing of APP into recycling endosomes containing BACE-1
(Figures 3 and 4), along with increased b-cleavage of APP (Fig-
ure 4F). Early studies in cell lines suggested that APP/BACE-1
convergence occurs at or perhaps near the plasma membrane
(Kinoshita et al., 2003; von Arnim et al., 2008), but more recent
data (also mostly in nonneuronal cells or neuronal cell lines) sug-
gest that these two proteins converge within early endosomes
(Rajendran et al., 2006; Sannerud et al., 2011). Other studies
show that APP andRab5may colocalize in presynaptic terminals
(Ikin et al., 1996; Sabo et al., 2003). However, in our experiments,
mobile BACE-1 vesicles in dendrites show scant colocalization
with Rab-5, a marker of early endosomes (Figure 2B, bottom).
Moreover, although APP is routed to TfR-positive recycling
endosomes upon glycine or PTX stimulation (Figure 4B), there
is no increase in APP colocalization with Rab-5 upon activity
induction (Figure 4C). Though these data suggest that the activ-
ity-induced convergence of APP and BACE-1 occur in neuronal
recycling endosomes, we cannot exclude the possibility of such
Figure 7. Endogenous APP and BACE-1 in Postmortem Control and AD Brains
(A) Frozen human control and AD brains were homogenized and fractionated (n = 10 brains in each group, see Figure S6). P100 ‘‘vesicle-pellet’’ fractions were
layered and separated on sucrose density gradients and immunoblotted with antibodies to APP and BACE-1. Similar to mouse brain homogenates (Figure 1E),
endogenous APP and BACE-1 were largely localized to separate density fractions. However, in AD brains, more APP was seen in the highest-density fractions
that also contain BACE-1 (fractions 10, hatched red box), suggesting APP/BACE-1 convergence.
(B) Densitometry analysis of the APP/BACE-1 fractions. For a given protein, the band intensity in each lane was normalized to the maximum band intensity of that
protein over the ten lanes. Note the relative increases in APP band intensities in higher-density fractions from AD brains (red dashed box).
(C) Average APP blot intensities plotted from the data shown in (B). Note the shift in APP distribution to higher-density fractions in AD brains. (*p < 0.05; two-tailed,
unpaired t test).
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Activity-Induced APP/BACE-1 Convergenceconvergence in early endosomes as well. For example, given the
known dynamics of endosomes, a transitory convergence of
APP/BACE-1 in early endosomes (before their appearance in
recycling compartments) is conceivable. Nevertheless, the avail-
able data supports our model (Figure 6A, pathway [1]) and pro-
vides a potential starting point for further work that may more
precisely pinpoint the temporal kinetics of such convergence.
What are the specific cell biological mechanisms that lead to
activity-dependent APP/BACE-1 convergence? A recent studysuggested that activity-dependent APP processing may occur
in cholesterol-rich microdomains (Sakurai et al., 2008). Worley
and colleagues also recently showed that activity-induced Arc
induction led to increased g-secretase processing of APP in
dendrites (Wu et al., 2011), but early mechanisms leading to
the convergence of APP/BACE-1—initiating the rate-limiting
step of b-cleavage—remained unclear. We found that endocy-
tosis of APP is essential for the activity-dependent convergence
of APP/BACE-1 in neurons (Figure 6). Specifically, experimentalNeuron 79, 447–460, August 7, 2013 ª2013 Elsevier Inc. 457
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Activity-Induced APP/BACE-1 Convergenceparadigms blocking clathrin-mediated endocytosis (or APP
endocytosis) also abrogated APP/BACE-1 convergence (Figures
6C and 6D), and such conditions led to expected stalling and
clustering of APP and clathrin (Figure 6E), suggesting that a recy-
cling-dependent pathway (as opposed to homotypic fusion) is
responsible for this convergence.
What is the relevance of our findings to human disease?
Studies show that amyloid plaque deposition is most conspicu-
ous in the ‘‘default mode network’’—a circuit that ismetabolically
active during unidirectedmentation (Buckner et al., 2009)—lead-
ing to the hypothesis that activity-dependent amyloidogenesis
may play a role in AD (Bero et al., 2011). Though our experiments
do not address this directly, our finding that APP/BACE-1
convergence is exaggerated in stimulated neurons as well as
AD brains is consistent with this idea. However, other studies
implicate defective Ab clearance (and not increased Ab produc-
tion) as the primary pathologic event in AD (Mawuenyega et al.,
2010), and further work is needed to clarify these issues. In sum-
mary, our studies uncover fundamental trafficking strategies by
which neurons largely restrict APP (substrate) and BACE-1
(enzyme) in distinct organelles—thus limiting Ab biogenesis in
physiologic states (Figures 1 and 2); define a trafficking pathway
by which APP and BACE-1 converge upon induction of neuronal
activity (Figures 3, 4, 5, and 6); and, finally, our data from human
brains (Figure 7) suggest potential relevance of these mecha-
nisms in human disease.
EXPERIMENTAL PROCEDURES
DNA Constructs, Antibodies, and Reagents
Several constructs were obtained from other laboratories, as mentioned in the
Acknowledgments. TheCFP/YFP tags in theBACE-1:CFP/APP:YFPconstructs
were replaced by GFP or mCherry, cloned in-frame, and confirmed by
sequencing (see Figure S1). The promoter in the NPYss construct (Banker lab-
oratory) was swapped with CMV. The clathrin:GFP and Rab-5:mCherry con-
structs were obtained from Addgene. Antibodies used for biochemistry were
the following: APP (1565-1; Epitomics), BACE1 (MAB931; R&D), TfR (clone
H68.4; Invitrogen), Tubulin (clone DM1A, Sigma), anti-pan cadherin (ab22744,
Abcam), KDEL (Ab12223, Abcam), Rab11 (71-5300, Invitrogen), GM130
(610822, BD Transduction), and Rab5 (108011, Synaptic Systems). D-AP5,
dynasore, picrotoxin, and memantine were from Sigma and Alexa 488 Trans-
ferrin was from Molecular Probes. Beta-secretase Inhibitor II (Calbiochem)
was prepared in DMSO and neurons were treated with final 0.5 mM inhibitors
for 24 hr.
Hippocampal Cultures and Transfection
Primary hippocampal neurons were obtained from postnatal (P0–P1) CD-1
mice and cells were transfected using Lipofectamine-2000 (Invitrogen) as
described previously in Roy et al. (2012). Briefly, dissociated neurons were
plated at a density of 50,000 cells/cm2 in poly-D-lysine-coated (1.0 mg/ml)
glass-bottom culture dishes (MatTek) and maintained in Neurobasal/B27
media (Invitrogen) supplemented with 0.5 mM glutamine. All experiments
examining colocalization in fixed neurons, as well as all experiments with cla-
thrin:GFP, were performed in DIV15–DIV18 neurons. All transport assays were
performed in DIV6–DIV8 neurons, as thicker dendrites in older neurons pre-
cluded reliable imaging. All animal studies were carried out in accordance
with University of California guidelines.
Microscopy, Live Cell Imaging, and Transport Data Analysis
All assays were performed 4–6 hr posttransfection, on low expressers,
except when noted in the figures. For each group, we analyzed 100–200
vesicles from 10–15 dendrites, and each experiment was repeated in at least458 Neuron 79, 447–460, August 7, 2013 ª2013 Elsevier Inc.two to three separate sets of cultures. Just before imaging, neurons were
transferred to Hibernate-E-based ‘‘live imaging’’ at 35C–37C (Roy et al.,
2012). Distal region of the primary dendrite or the secondary dendrites
(first-order branch) were selected for imaging. All time-lapse movies were
acquired using an Olympus IX81 inverted epifluorescence microscope with
a Z-controller (IX81, Olympus), a motorized X-Y stage controller (Prior Scien-
tific), and a fast electronic shutter (SmartShutter). Images were acquired
using an ultrafast light source (Exfo exacte) and high-performance charge-
coupled device cameras (Coolsnap HQ2, Photometrics). Image acquisitions
were performed using MetaMorph software (Molecular Device). Simulta-
neous imaging of two spectrally distinct fluorophores was performed using
a ‘‘dual cam’’ imaging system (Photometrics), a device that splits the emis-
sion wavelengths into separate (red/green) channels. Fluorescence intensity
was attenuated to 50% to minimize photobleaching. Imaging parameters
were set at 1 frame/s, total 200 frames and 200–400 ms exposure with
2 3 2 camera binning, totaling to 2,000 s of total imaging time for each
group, suitable to capture the infrequent transport events in dendrites.
For transport analysis, kymographs were generated in MetaMorph, and
segmental tracks were traced on the kymographs using a line tool and
individual lines were saved as ‘‘.rgn’’ files, and the resultant velocity data
(distance/time) were obtained for each track as described in Tang et al.
(2012). Frequencies of particle movements were calculated by dividing the
number of individual particles moving in a given direction by the total number
of analyzed particles in the kymograph. For cotransport assays, dual cam
videos were separated using ‘‘split view’’ menu and kymographs were
generated for each channel (red/green). Segmental tracks were traced as
mentioned above and individual lines were compared manually for each
pair of kymographs for one particular video. Vesicles (red/ green) were
considered cotransported/colocalized if the traced lines merged when
kymographs were overlaid.
Colocalization Analysis
Neuronswere cotransfectedwith desired constructs, and cells were fixed after
6–12 hr using 4% paraformaldehyde/4% sucrose. Z stack images were
captured using a 1003 objective with these constant imaging parameters:
0.2 mm z step, 400–800 ms exposure, 1 3 1 binning, and deconvolved using
the ‘‘Classic Maximum Likelihood Estimation’’ algorithm (Huygens, Scientific
Volume Imaging B.V.). Deconvolved z stacks were then subjected to a
maximum intensity projection, resulting in two-dimensional (2D) images for
processing. Subsequent processing for all images was as performed in three
steps as described below: (1) registration between images was optimized
using a 2D cross-correlation algorithm, (2) images were thresholded, and (3)
colocalization was calculated as the fraction of area overlapping between
the above-threshold structures in each image. Image alignment and colocali-
zation analysis was performed using custom algorithms written in MATLAB
(MathWorks). For temperature block experiments, cells were first imaged at
37C, followed by 2 hr incubation at 20C, and reimaged.
Activity Induction, Drug Treatments, and Alexa TfR Labeling
Glycine stimulation was performed in DIV15–DIV17 neurons, essentially as
described by Park et al. (2006). Briefly, neurons were incubated at 37C for
5 min in E4 solution containing 124 mM NaCl, 2 mM CaCl2, 3 mM KCl,
10mMHEPES, and 10mMglucose (pH 7.4). Activity was inducedwith E4 sup-
plemented with 20 mMbicuculine and 200 mMglycine for 5min, and finally in E4
with 20 mM bicuculine for 15 min before fixation and imaging. For picrotoxin
(PTX) stimulation, cells were incubated in 100 mM PTX at 37C for the desired
time and fixed. In experiments with NMDA inhibitors, neurons were either
treated with 50 mM D-APV for 2 hr or 10 mMmemantine for 4 hr and then acti-
vation asmentioned in the text. Dynasore was used at 40 mM for 30min at 37C
prior to activity induction and imaging. To test the pHl:APP (see Figure 5B), we
replaced neurons incubated in HEPES with MES to obtain a pH of 5.5, keeping
other components in the remaining imaging buffer unchanged (124 mM NaCl,
2 mM CaCl2, 3 mM KCl, 10 mM MES, and 10 mM glucose [pH 5.5]), as
described by Park et al. (2006). To label actively recycling endosomes, we
loaded neurons with 50 mg/ml Alexa 488 transferrin (Invitrogen) diluted in imag-
ing medium for 1 hr at 37C, rinsed extensively, and imaged immediately
thereafter.
Neuron
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Sequential isolation and density gradient centrifugation were performed to
fractionate vesicular fractions as described previously by Scott et al. (2011).
Briefly, brains from 4- to 6-week-old CD-1 mice, or frontal lobe dissected
from postmortem frozen human brains (three AD Braak V/VI and two controls,
obtained from the AD Research Center brain bank at UCSD), were homoge-
nized in buffer containing 20 mM HEPES, 40 mM KCl, 5 mM EDTA, 5 mM
EGTA, and protease inhibitor (pH 7.2). Tissue lysate was centrifuged at
1,000 3 g for 15 min to isolate postnuclear supernatant (S1). S1 was centri-
fuged at 10,200 3 g for 20 min to obtain synaptosome-depleted fraction
(S2). Finally, S2 fraction was centrifuged at 100,0003 g for 1 hr at 4 to isolate
soluble (S100) and vesicular (P100) fraction. For floatation assays, P100 frac-
tionswere adjusted to 45%sucrose and bottom loaded on a 5%–45%sucrose
gradient and centrifuged at 160,0003 g for 16 hr at 4C in an SW55-Ti rotor in
an Optima L-100 ultracentrifuge (Beckman-Coulter). Ten fractions of 0.5 ml
each were collected from top of the gradient column and equal volumes
were used for SDS-PAGE and western blot analysis. Blots were developed
by using Pierce Fast Western Blot kit ECL Substrate, visualized by using Versa
Doc Imaging system (Bio-Rad), and quantified by densitometry. For ex vivo
biochemical assays to detect APP-CTFs, DIV16–DIV18 neurons (50,000
cells/well) were treated with 100 mM PTX in presence of 100 nM gamma-sec-
retase inhibitor BMS-299897 (Anderson et al., 2005). Cells were lysed in
Laemmli buffer and resolved on 16% Tricine gel.
Statistical Analysis
Routine statistical analyses were performed using Prism software (Graphpad)
using the Student’s t test for comparing two groups and one-way ANOVA for
multiple groups. A p value of <0.05 was considered significant. For curve fitting
(Figure 1C), the Bayesian Information Criterion was used to select a second-
order Gaussian model for fitting of the velocity data.
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